{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:47:38Z","timestamp":1771505258398,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jaci.2016.04.042","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T22:44:47Z","timestamp":1466030687000},"page":"1089-1097.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease"],"prefix":"10.1016","volume":"138","author":[{"given":"Xin","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison K.","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Negri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7121-3271","authenticated-orcid":false,"given":"Mary Grace","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer C.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Steinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2016.04.042_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/alr.20003","article-title":"Trends in common rhinologic illnesses: analysis of U.S. healthcare surveys 1995-2007","volume":"1","author":"Mattos","year":"2011","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2016.04.042_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/0091-6749(94)90123-6","article-title":"Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma","volume":"94","author":"Fischer","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of resiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/CRIAI:24:2:159","article-title":"Aspirin desensitization in patients with AERD","volume":"24","author":"Stevenson","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/all.12440","article-title":"Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis","volume":"69","author":"Miljkovic","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.04.042_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/cea.12462","article-title":"Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia","volume":"45","author":"Ho","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.04.042_bib12","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/lary.21969","article-title":"Evidence for distinct histologic profile of nasal polyps with and without eosinophilia","volume":"121","author":"Payne","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2016.04.042_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1067\/mai.2003.67","article-title":"Cytseinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma","volume":"111","author":"Steinke","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2016.04.042_bib16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotiene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"Perez-Novo","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib17","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.4049\/jimmunol.1101806","article-title":"Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation","volume":"187","author":"Luna-Gomes","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib18","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1365-2222.2006.02528.x","article-title":"Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis","volume":"36","author":"Okano","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2016.04.042_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archotol.133.7.693","article-title":"Expression of prostaglandin D2 synthase in activated eosinophils in nasal polyps","volume":"133","author":"Hyo","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2016.04.042_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4049\/jimmunol.1301753","article-title":"Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease","volume":"193","author":"Steinke","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib21","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2013.05.008","article-title":"Prominent role of interferon-\u03b3 in aspirin-exacerbated respiratory disease","volume":"132","author":"Steinke","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1165\/rcmb.2006-0252OC","article-title":"Concordant\u00a0modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-\u03b3 on peripheral immune cells","volume":"36","author":"Early","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2016.04.042_bib23","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10875-011-9589-4","article-title":"Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression","volume":"31","author":"Hudson","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2016.04.042_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2016.04.042_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1183\/09031936.93.06030391","article-title":"Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma","volume":"6","author":"Sladek","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2016.04.042_bib27","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","article-title":"Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway","volume":"195","author":"Liu","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib28","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2016.04.042_bib29","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics","volume":"157","author":"Dahlen","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2016.04.042_bib30","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.jchromb.2010.05.012","article-title":"Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects","volume":"878","author":"Sanak","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jaci.2016.04.042_bib31","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/all.12512","article-title":"Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity","volume":"69","author":"Mastalerz","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2016.04.042_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2016.04.042_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.prostaglandins.2003.12.002","article-title":"Expression of prostaglandin D synthase and the prostaglandin D2 receptors DP and CRTH2 in human nasal mucosa","volume":"73","author":"Nantel","year":"2004","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.jaci.2016.04.042_bib34","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.179.7.4792","article-title":"The role of the prostaglandin D2 receptor, DP, in eosinophil trafficking","volume":"179","author":"Schratl","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaci.2014.08.027","article-title":"D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells","volume":"135","author":"Stinson","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib36","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4049\/jimmunol.176.3.1326","article-title":"Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in\u00a0vivo role of endogenous eotaxin","volume":"176","author":"Mesquita-Santos","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.104.074823","article-title":"Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of\u00a0CD203c and CD11b by basophils","volume":"312","author":"Monneret","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2016.04.042_bib38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0091-6749(95)70298-9","article-title":"Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis","volume":"96","author":"Hamilos","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1165\/ajrcmb.20.3.3060","article-title":"Immunolocalization of CD34 in nasal polyp. Effect of topical corticosteroids","volume":"20","author":"Kim","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"suppl","key":"10.1016\/j.jaci.2016.04.042_bib40","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1136\/thorax.55.suppl_2.S24","article-title":"Haemopoietic mechanisms in nasal polyposis and asthma","volume":"55","author":"Denburg","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2016.04.042_bib41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1378\/chest.08-0485","article-title":"Eosinophil progenitors in airway diseases: clinical implications","volume":"134","author":"Denburg","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2016.04.042_bib42","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2009.12.977","article-title":"Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers","volume":"125","author":"Higashi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1164\/ajrccm.153.2.8564100","article-title":"Inhaled\u00a0PgE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma","volume":"153","author":"Sestini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2016.04.042_bib44","doi-asserted-by":"crossref","first-page":"16987","DOI":"10.1073\/pnas.1313185110","article-title":"Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes","volume":"110","author":"Liu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2016.04.042_bib45","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaci.2013.12.1034","article-title":"Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease","volume":"133","author":"Laidlaw","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/JAA.S88739","article-title":"Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances","volume":"10","author":"Steinke","year":"2016","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2016.04.042_bib47","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","article-title":"Cyclooxygenase-independent actions of cyclooxygenase inhibitors","volume":"15","author":"Tegeder","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2016.04.042_bib48","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","article-title":"Survey-defined patient experiences with aspirin-exacerbated respiratory disease","volume":"3","author":"Ta","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2016.04.042_bib49","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2016.04.042_bib50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2016.04.042_bib51","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2016.04.042_bib52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916304407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674916304407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:00:08Z","timestamp":1758790808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674916304407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0091674916304407"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2016.04.042","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2016.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}